daGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT (clinicaltrials.gov) - Oct 22, 2026 - P3 | N=438 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Initiation date: Jun 2026 ➔ Jan 2027
Trial initiation date • Acute Graft versus Host Disease • Bone Marrow Transplantation • Graft versus Host Disease • Immunology • Transplantation
|